Brought to you by 
J&J buys Micrus Endovascular for $480mm
Jul 2010
Executive Summary
Johnson & Johnson has agreed to acquire Micrus Endovascular Corp. (devices for cerebral vascular diseases) for $480mm in cash. Investors will receive $23.40 per Micrus share (an 11% premium).
Deal Industry
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Payment Includes Cash
- Full Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
J&J buys Micrus Endovascular for $480mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice